Class Action

Walgreens Pain Relieving Lidocaine Patches

Class Action

Walgreens Pain Relieving Lidocaine Patches


Case Name (Date)

Stevens et al v. Walgreen Co.
21-cv-10603, S.D.N.Y.
(Dec. 2021)

Toporek et al. v. Walgreen Co.
22-cv-4766, E.D.N.Y.
(April 2022)


Product/Service

Walgreens Pain Relieving Lidocaine Patches


Allegations

Misleadingly marketing products as “maximum strength” when other products contain the same amount of or more lidocaine

Misleadingly marketing that patches stay on for “up to 12 hours” when they regularly peel within a few hours or minutes


Status

Pending



Class-Action Tracker

Walgreens Acne Products

Class Action

Walgreens Acne Products

Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene

Several Store Brand Acetaminophen Products

Class Action

Several Store Brand Acetaminophen Products

Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children

Walgreens’ Infants’ Pain & Fever Acetaminophen

Class Action

Walgreens’ Infants’ Pain & Fever Acetaminophen

Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…


The Latest

Filters


Show More